AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9364949 — intervention group
Group type: EXPERIMENTAL
Intervention: 60% w/v barium sulfate plus 2.5% w/v bentonite
Number of subjects: 20
Study 9364949 — intervention group
Group type: COMPARATOR
Intervention: 220% w/v barium sulfate
Number of subjects: 20
Study 8222684 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective digestive decontamination (oral antibiotics: polymyxin E, tobramycin, and amphotericin B)
Number of subjects: 80
Study 8222684 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 80
Study 3096221 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin
Number of subjects: 0
Study 3096221 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 31413010 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib plus metformin
Number of subjects: 224
Study 31413010 — intervention group
Group type: COMPARATOR
Intervention: Gefitinib plus placebo
Number of subjects: 224
Study 29030864 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingenol mebutate 0·015% gel
Number of subjects: 0
Study 29030864 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac sodium 3% gel
Number of subjects: 0
Study 28086200 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy with liquid nitrogen
Number of subjects: 180
Study 28086200 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy
Number of subjects: 180
Study 25429531 — intervention group
Group type: EXPERIMENTAL
Intervention: HC-A II
Number of subjects: 277
Study 25429531 — intervention group
Group type: COMPARATOR
Intervention: HTK
Number of subjects: 277
Study 23653899 — intervention group
Group type: EXPERIMENTAL
Intervention: CoJet Sand
Number of subjects: 72
Study 23653899 — intervention group
Group type: EXPERIMENTAL
Intervention: Lava Ceram liner
Number of subjects: 72
Study 23653899 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive ZirLiner
Number of subjects: 72
Study 23653899 — intervention group
Group type: EXPERIMENTAL
Intervention: Panavia F
Number of subjects: 72
Study 23653899 — intervention group
Group type: EXPERIMENTAL
Intervention: RelyX Unicem
Number of subjects: 72
Study 23653899 — intervention group
Group type: COMPARATOR
Intervention: Nontreated specimens
Number of subjects: 72
Study 23653899 — intervention group
Group type: COMPARATOR
Intervention: Specimens treated with CoJet Sand
Number of subjects: 72
Study 23653899 — intervention group
Group type: COMPARATOR
Intervention: Specimens treated with liners
Number of subjects: 72
Study 20951323 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness (measured in METs)
Number of subjects: 2368
Study 20951323 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness added to conventional risk factors
Number of subjects: 2368
Study 18412566 — intervention group
Group type: EXPERIMENTAL
Intervention: Aged and menopaused receiving hormonal replacement therapy
Number of subjects: 4
Study 18412566 — intervention group
Group type: EXPERIMENTAL
Intervention: Aged and menopaused
Number of subjects: 4
Study 18412566 — intervention group
Group type: EXPERIMENTAL
Intervention: Aged with normal menses
Number of subjects: 4
Study 18412566 — intervention group
Group type: EXPERIMENTAL
Intervention: Young with normal menses
Number of subjects: 4
Study 18412566 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 4
Study 16357330 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline pleurodesis (103 patients)
Number of subjects: 202
Study 16357330 — intervention group
Group type: COMPARATOR
Intervention: Observation (99 patients)
Number of subjects: 202
Study 16357330 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline pleurodesis
Number of subjects: 202
Study 16357330 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline pleurodesis and Observation
Number of subjects: 202
Study 14594941 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with supportive care to control non-hematological adverse events (nausea/vomiting, anorexia, diarrhea)
Number of subjects: 377
Study 14594941 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 377
Study 14594941 — intervention group
Group type: COMPARATOR
Intervention: Control of non-hematological adverse events
Number of subjects: 377
Study 10919591 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 1 g twice daily (n=34)
Number of subjects: 64
Study 10919591 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA) 2 mg/kg (n=30)
Number of subjects: 64
Study 10919591 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose reduction of MMF to 500 mg twice daily
Number of subjects: 64
Study 10919591 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose reduction of AZA to 1.0 mg/kg
Number of subjects: 64
Study 10919591 — intervention group
Group type: COMPARATOR
Intervention: Both groups (MMF and AZA)
Number of subjects: 64
Study 8160596 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillators (ICDs)
Number of subjects: 0
Study 8160596 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical therapy (amiodarone)
Number of subjects: 0
Study 3168726 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorbinil (250 mg/day)
Number of subjects: 19
Study 3168726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 29958219 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided practice
Number of subjects: 15
Study 29958219 — intervention group
Group type: COMPARATOR
Intervention: Non-US (NUS) practice
Number of subjects: 15
Study 27978511 — intervention group
Group type: EXPERIMENTAL
Intervention: Daprodustat 4 mg
Number of subjects: 97
Study 27978511 — intervention group
Group type: EXPERIMENTAL
Intervention: Daprodustat 6 mg
Number of subjects: 97
Study 27978511 — intervention group
Group type: EXPERIMENTAL
Intervention: Daprodustat 8 mg
Number of subjects: 97
Study 27978511 — intervention group
Group type: EXPERIMENTAL
Intervention: Daprodustat 10 mg
Number of subjects: 97
Study 27978511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 27881458 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (HD) group: 2 + 2 mg 17B-estradiol/day orally
Number of subjects: 20
Study 27881458 — intervention group
Group type: COMPARATOR
Intervention: Low-dose (LD) group: 2 mg 17B-estradiol/day orally and placebo
Number of subjects: 20
Study 24088429 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided radial access
Number of subjects: 183
Study 24088429 — intervention group
Group type: COMPARATOR
Intervention: Palpation-guided radial access
Number of subjects: 183
Study 24088429 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided attempt after palpation failure
Number of subjects: 183
Study 27027075 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with an 830 nm gallium-aluminum-arsenic laser at 30 mW
Number of subjects: 58
Study 27027075 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 58
Study 19654505 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (2.5 mg/70 kg)
Number of subjects: 16
Study 19654505 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (5.0 mg/70 kg)
Number of subjects: 16
Study 19654505 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (10.0 mg/70 kg)
Number of subjects: 16
Study 19654505 — intervention group
Group type: EXPERIMENTAL
Intervention: diazepam (2.5 mg/70 kg)
Number of subjects: 16
Study 19654505 — intervention group
Group type: EXPERIMENTAL
Intervention: diazepam (5.0 mg/70 kg)
Number of subjects: 16
Study 19654505 — intervention group
Group type: EXPERIMENTAL
Intervention: diazepam (10.0 mg/70 kg)
Number of subjects: 16
Study 19654505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 17588387 — intervention group
Group type: EXPERIMENTAL
Intervention: Stentless aortic valves
Number of subjects: 919
Study 15546074 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 540
Study 15546074 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 540
Study 15546074 — intervention group
Group type: COMPARATOR
Intervention: Penicillin G
Number of subjects: 540
Study 11158812 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy for ROP
Number of subjects: 291
Study 11158812 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 291
Study 9924226 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser stimulation of acupuncture point P6
Number of subjects: 100
Study 9924226 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 100
Study 7852518 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonists
Number of subjects: 26
Study 2185814 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% dextrose water 10 ml kg‐1 orally about 4 h before operation
Number of subjects: 20
Study 2185814 — intervention group
Group type: COMPARATOR
Intervention: No oral intake after midnight (fasted group)
Number of subjects: 20
Study 286492 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG-CWS and chemotherapy as maintenance therapy
Number of subjects: 11
Study 286492 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 11
Study 286492 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG-CWS therapy
Number of subjects: 11
Study 31163446 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT-D+MTX
Number of subjects: 149
Study 31163446 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT-D
Number of subjects: 149
Study 31163446 — intervention group
Group type: COMPARATOR
Intervention: MTX
Number of subjects: 149
Study 28295147 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-rebreather mask
Number of subjects: 30
Study 28295147 — intervention group
Group type: EXPERIMENTAL
Intervention: Bag-valve-mask
Number of subjects: 30
Study 28295147 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable ventilator
Number of subjects: 30
Study 26056753 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral subcostal TAP blocks with liposomal bupivacaine
Number of subjects: 0
Study 26056753 — intervention group
Group type: COMPARATOR
Intervention: Bilateral subcostal TAP blocks with bupivacaine
Number of subjects: 0
Study 23895984 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical mitomycin C (MMC) application
Number of subjects: 40
Study 23895984 — intervention group
Group type: COMPARATOR
Intervention: Placebo application
Number of subjects: 40
Study 22004765 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanezumab 25 μg/kg
Number of subjects: 83
Study 22004765 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanezumab 100 μg/kg
Number of subjects: 83
Study 22004765 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanezumab 200 μg/kg
Number of subjects: 83
Study 22004765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 19496921 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised patient self-testing (PST) using an internet-based expert system
Number of subjects: 162
Study 19496921 — intervention group
Group type: COMPARATOR
Intervention: Anticoagulation management service (AMS)
Number of subjects: 162
Study 16914600 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (2.5 mg/day)
Number of subjects: 31
Study 16914600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 15362523 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese traditional medicine, indomethacin, and three kinds of antibacterial agents
Number of subjects: 86
Study 15362523 — intervention group
Group type: COMPARATOR
Intervention: Chinese traditional medicine and indomethacin only
Number of subjects: 86
Study 15362523 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibacterial agents
Number of subjects: 86
Study 11375357 — intervention group
Group type: EXPERIMENTAL
Intervention: Nateglinide (120 mg before three meals daily, n = 51)
Number of subjects: 152
Study 11375357 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyburide (5 mg q.d. titrated to 10 mg q.d. after 2 weeks, n = 50)
Number of subjects: 152
Study 11375357 — intervention group
Group type: EXPERIMENTAL
Intervention: Nateglinide
Number of subjects: 152
Study 11375357 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 51)
Number of subjects: 152
Study 9225934 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEPO) 141 U/kg subcutaneously, 6 injections between Days -21 and -7, along with 200 mg of iron saccharose complex intravenously at each visit.
Number of subjects: 50
Study 9225934 — intervention group
Group type: COMPARATOR
Intervention: Placebo, along with 200 mg of iron saccharose complex intravenously at each visit.
Number of subjects: 50
Study 7943463 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose TRH (0.5 mg) administered 5 minutes after ECT session 3 or 4
Number of subjects: 8
Study 7943463 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 8
Study 3148039 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 days of intravenous nutrition
Number of subjects: 34
Study 3148039 — intervention group
Group type: COMPARATOR
Intervention: Control group (surgery at the next convenient operation list)
Number of subjects: 34
Study 31841699 — intervention group
Group type: EXPERIMENTAL
Intervention: BGF MDI 320/18/9.6 μg
Number of subjects: 30
Study 30310698 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (1g nutraceutical formulation)
Number of subjects: 47
Study 27590743 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low Nicotine Content (VLNC) cigarettes
Number of subjects: 0
Study 27590743 — intervention group
Group type: COMPARATOR
Intervention: Normal Nicotine Content (NNC) cigarettes
Number of subjects: 0
Study 25637318 — intervention group
Group type: EXPERIMENTAL
Intervention: CSE-NE (Clearfil SE Bond without prior selective phosphoric acid-etching)
Number of subjects: 29
Study 25637318 — intervention group
Group type: EXPERIMENTAL
Intervention: CSE-E (Clearfil SE Bond with prior selective phosphoric acid-etching)
Number of subjects: 29
Study 21029154 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular prosthesis (two types)
Number of subjects: 173
Study 21029154 — intervention group
Group type: EXPERIMENTAL
Intervention: Denture problems
Number of subjects: 173
Study 21029154 — intervention group
Group type: EXPERIMENTAL
Intervention: General health
Number of subjects: 173
Study 21029154 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health-related quality of life
Number of subjects: 173
Study 20800102 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol before conditioning
Number of subjects: 20
Study 20800102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 17906911 — intervention group
Group type: EXPERIMENTAL
Intervention: AHSCT (Autologous hematopoietic stem cell transplant)
Number of subjects: 13
Study 16178295 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser irradiation
Number of subjects: 44
Study 16178295 — intervention group
Group type: COMPARATOR
Intervention: Placebo 'light source'
Number of subjects: 44
Study 16178295 — intervention group
Group type: COMPARATOR
Intervention: Standardised treatment only
Number of subjects: 44
Study 12837711 — intervention group
Group type: EXPERIMENTAL
Intervention: CQI intervention for beta-blockade
Number of subjects: 267917
Study 12837711 — intervention group
Group type: EXPERIMENTAL
Intervention: CQI intervention for IMA grafting
Number of subjects: 267917
Study 12837711 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 267917
Study 10663450 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 8
Study 10663450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 9002332 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits by non-health workers to mothers of children under five, followed by referrals to routine clinics and subsequent visits by nurses for those who failed to complete immunization schedules.
Number of subjects: 200
Study 9002332 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits in a neighboring town with a similar strategy.
Number of subjects: 200
Study 9002332 — intervention group
Group type: COMPARATOR
Intervention: Control group of age-matched children in town 1.
Number of subjects: 200
Study 1463177 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol induction (1.5-2.5 mg/kg)
Number of subjects: 50
Study 1463177 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional propofol (0.5 mg/kg/30s)
Number of subjects: 50
Study 1463177 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol induction
Number of subjects: 50
Study 6526092 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifonazole
Number of subjects: 8
Study 6526092 — intervention group
Group type: COMPARATOR
Intervention: Clotrimazole
Number of subjects: 8
Study 30535398 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic dietary red meat
Number of subjects: 113
Study 30535398 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic dietary white meat
Number of subjects: 113
Study 30535398 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic dietary non-meat protein
Number of subjects: 113
Study 30535398 — intervention group
Group type: COMPARATOR
Intervention: Dietary-saturated fat
Number of subjects: 113
Study 29772833 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein human milk fortifier (HMF) providing 1.8 g protein per 100 mL expressed breast milk (EBM)
Number of subjects: 60
Study 29772833 — intervention group
Group type: COMPARATOR
Intervention: Standard human milk fortifier (HMF) providing 1 g protein per 100 mL expressed breast milk (EBM)
Number of subjects: 60
Study 27435171 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinovuyo Teen parenting support programme (14 sessions)
Number of subjects: 40
Study 27435171 — intervention group
Group type: COMPARATOR
Intervention: Water hygiene programme (1-day attention-control)
Number of subjects: 40
Study 27435171 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinovuyo Teen parenting support programme
Number of subjects: 40
Study 25376396 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose behavioral treatment (16 sessions)
Number of subjects: 612
Study 25376396 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-dose behavioral treatment (32 sessions)
Number of subjects: 612
Study 25376396 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose behavioral treatment (48 sessions)
Number of subjects: 612
Study 25376396 — intervention group
Group type: COMPARATOR
Intervention: Control condition (nutrition education without behavior modification)
Number of subjects: 612
Study 23118302 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin therapy (20 mg/d) for 12 months
Number of subjects: 6851
Study 23118302 — intervention group
Group type: COMPARATOR
Intervention: Baseline Lp-PLA(2) activity
Number of subjects: 6851
Study 23118302 — intervention group
Group type: COMPARATOR
Intervention: Baseline Lp-PLA(2) mass
Number of subjects: 6851
Study 23118302 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin-induced change in Lp-PLA(2) activity
Number of subjects: 6851
Study 18855128 — intervention group
Group type: EXPERIMENTAL
Intervention: St. Jude Riata leads (6.3- and 7.3-French leads)
Number of subjects: 593
Study 18855128 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic Sprint Fidelis 6949 lead (6.6 French lead)
Number of subjects: 593
Study 18855128 — intervention group
Group type: COMPARATOR
Intervention: Overall population (593 cases)
Number of subjects: 593
Study 17170721 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HD MTX) at 1.5 g/m(2)/2 weeks x 6 in Lower-risk group
Number of subjects: 1395
Study 17170721 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HD MTX) at 8 g/m(2)/2 weeks x 4 in Intermediate-risk group
Number of subjects: 1395
Study 17170721 — intervention group
Group type: COMPARATOR
Intervention: Low-dose methotrexate (LD MTX) at 25 mg/m(2)/week in Lower-risk group
Number of subjects: 1395
Study 17170721 — intervention group
Group type: COMPARATOR
Intervention: Low-dose methotrexate (LD MTX) in Intermediate-risk group
Number of subjects: 1395
Study 17170721 — intervention group
Group type: EXPERIMENTAL
Intervention: Age >10 years
Number of subjects: 1395
Study 17170721 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HD MTX)
Number of subjects: 1395
Study 17170721 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal neuropathy
Number of subjects: 1395
Study 17170721 — intervention group
Group type: EXPERIMENTAL
Intervention: Encephalopathy
Number of subjects: 1395
Study 15206660 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/d
Number of subjects: 135
Study 15206660 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg/d
Number of subjects: 135
Study 15206660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 11361045 — intervention group
Group type: EXPERIMENTAL
Intervention: Onion supplement (100 mg quercetin)
Number of subjects: 12
Study 11361045 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin‐4'‐O‐glucoside (100 mg quercetin)
Number of subjects: 12
Study 11361045 — intervention group
Group type: EXPERIMENTAL
Intervention: Buckwheat tea (200 mg quercetin)
Number of subjects: 12
Study 11361045 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin‐3‐O‐rutinoside (200 mg quercetin)
Number of subjects: 12
Study 9465696 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent implantation
Number of subjects: 0
Study 9465696 — intervention group
Group type: COMPARATOR
Intervention: Balloon coronary angioplasty (PTCA)
Number of subjects: 0
Study 7805372 — intervention group
Group type: EXPERIMENTAL
Intervention: CuT 200
Number of subjects: 4808
Study 7805372 — intervention group
Group type: EXPERIMENTAL
Intervention: CuT 380A
Number of subjects: 4808
Study 7805372 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose combined oral contraceptives (OCs)
Number of subjects: 4808
Study 3170454 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioridazine high dose (2.50 mg/kg per day)
Number of subjects: 11
Study 3170454 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioridazine low dose (1.25 mg/kg per day)
Number of subjects: 11
Study 3170454 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 3170454 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioridazine (both doses)
Number of subjects: 11